Sudeep Pharma Stock Price Analysis and Quick Research Report. Is Sudeep Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sudeep Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sudeep Pharma has a PE ratio of 80.2573993464746 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sudeep Pharma has ROA of 18.1565% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sudeep Pharma has a Current ratio of 2.3928.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sudeep Pharma has a ROE of 25.1154%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sudeep Pharma has a Debt to Equity ratio of 0.2746 which means that the company has low proportion of debt in its capital.

• Sales growth: Sudeep Pharma has reported revenue growth of 3.7738% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sudeep Pharma for the current financial year is 37.2356207100124%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sudeep Pharma is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sudeep Pharma is Rs 8.4771. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sudeep Pharma in Ticker for free. Also, one can get the intrinsic value of Sudeep Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sudeep Pharma FAQs

Q1. What is Sudeep Pharma share price today?
Ans: The current share price of Sudeep Pharma is Rs 680.35.

Q2. What is the market capitalisation of Sudeep Pharma?
Ans: Sudeep Pharma has a market capitalisation of Rs 7684.459701875 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sudeep Pharma?
Ans: The PE ratio of Sudeep Pharma is 80.2573993464746 and the P/B ratio of Sudeep Pharma is 14.6572822143516, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sudeep Pharma share?
Ans: The 52-week high share price of Sudeep Pharma is Rs 795, and the 52-week low share price of Sudeep Pharma is Rs 631.45.

Q5. Does Sudeep Pharma pay dividends?
Ans: Currently, Sudeep Pharma does not pay dividends. Dividend yield of Sudeep Pharma is around 0%.

Q6. What are the face value and book value of Sudeep Pharma shares?
Ans: The face value of Sudeep Pharma shares is Rs 1, while the book value per share of Sudeep Pharma is around Rs 46.4172. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sudeep Pharma?
Ans: Sudeep Pharma has a total debt of Rs 118.1286 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sudeep Pharma?
Ans: The ROE of Sudeep Pharma is 25.1154% and ROCE of Sudeep Pharma is 28.7192%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sudeep Pharma a good buy for the long term?
Ans: The Sudeep Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sudeep Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sudeep Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sudeep Pharma’s financials?
Ans: You can review Sudeep Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.